Medical devices, healthcare technology and the business of care
510(k) clearance · K262412

Coronis Fusion 4MP (MDCC-4630); Coronis Fusion 6MP (MDCC-6630)

Barco NV · Decision date Oct 2, 2026

MEDTECHLEDGER EXPLANATIONK262412

What did the FDA decide?

FDA recorded a substantially equivalent (SE) decision for K262412 on 2026-10-02, covering the Coronis Fusion 4MP (MDCC-4630) and Coronis Fusion 6MP (MDCC-6630) under applicant Barco NV. The submission was received 07/15/2026 and reviewed in the Radiology panel, with product code PGY listed for the diagnostic radiology display category. SE denotes 510(k) clearance rather than PMA approval.

The record identifies the devices by model number but does not describe the specific component, software version or change that the submission addressed, and no summary statement is included in the available data. The decision therefore establishes clearance status only; comparative performance against the predicate, display specifications and any labeled indications remain in the underlying FDA documents, which were not reviewed here.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Oct 2, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262412
Regulatory pathway
510(k) premarket notification
Applicant
Barco NV
Product code
PGY
Decision code
SESE
Decision date
Oct 2, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Display, Diagnostic Radiology.

Applicant
Barco NV
Product code
PGY
FDA device class
2

FDA decision timeline

  1. K262412 received

    Application receipt date recorded by FDA.

  2. K262412 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code PGY

Product / regulatory recordCompanyPathwayDecision dateSource
Lg Electronics.Inc510(k) clearanceOct 2, 2026FDA
Eizo Corporation510(k) clearanceSep 1, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Barco NV

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Kortrijk

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records